Published on 5 Apr 2023 on Insider Monkey via Yahoo Finance

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2022 Earnings Call Transcript

Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2022 Earnings Call Transcript March 30, 2023

Operator: Thank you for standing by. This is the conference operator. Welcome to the Biora Therapeutics Fourth Quarter 2022 Financial Results Conference Call. As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. I would now like to turn the conference over to Chuck Padala, Managing Director with LifeSci Advisors, Biora's Investor Relations firm. Please, Chuck, go ahead.

Chuck Padala: Thank you, operator. Good afternoon, and welcome to the Biora Therapeutics fourth quarter 2022 corporate update and financial results conference call. Joining me on the call are Adi Mohanty, Chief Executive Officer; and Eric d'Esparbes, Chief Financial Officer. Before I turn the call over to Mr. Mohanty, I would like to remind you that today's call will include forward-looking statements within the meaning of the federal securities laws, including, but not limited to, the types of statements identified as forward-looking in our annual report on Form 10-K that we will file later today and our subsequent reports filed with the SEC, which are all available on our website in the Investors section. These forward-looking statements represent our views only as of the date of this call and involve substantial risks and uncertainties, including many that are beyond our control.